10-Q 1 htgc-20240331.htm 10-Q htgc-20240331
00012807842024Q112-31false0200.3333.3333.333300012807842024-01-012024-03-310001280784htgc:CommonStockParValueZeroPointZeroZeroOnePerShareMember2024-01-012024-03-310001280784htgc:SixPointTwoFiveNotesDueTwoThousandThirtyThreeMember2024-01-012024-03-3100012807842024-04-25xbrli:shares0001280784us-gaap:InvestmentUnaffiliatedIssuerMember2024-03-31iso4217:USD0001280784us-gaap:InvestmentUnaffiliatedIssuerMember2023-12-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2023-12-3100012807842024-03-3100012807842023-12-310001280784us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-03-310001280784us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-31iso4217:USDxbrli:shares0001280784us-gaap:InvestmentUnaffiliatedIssuerMember2024-01-012024-03-310001280784us-gaap:InvestmentUnaffiliatedIssuerMember2023-01-012023-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2024-01-012024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2023-01-012023-03-3100012807842023-01-012023-03-310001280784us-gaap:CommonStockMember2023-12-310001280784htgc:CapitalInExcessOfParValueMember2023-12-310001280784htgc:DistributableEarningsLossMember2023-12-310001280784htgc:DistributableEarningsLossMember2024-01-012024-03-310001280784us-gaap:CommonStockMember2024-01-012024-03-310001280784htgc:CapitalInExcessOfParValueMember2024-01-012024-03-310001280784us-gaap:CommonStockMember2024-03-310001280784htgc:CapitalInExcessOfParValueMember2024-03-310001280784htgc:DistributableEarningsLossMember2024-03-310001280784us-gaap:CommonStockMember2022-12-310001280784htgc:CapitalInExcessOfParValueMember2022-12-310001280784htgc:DistributableEarningsLossMember2022-12-3100012807842022-12-310001280784htgc:DistributableEarningsLossMember2023-01-012023-03-310001280784us-gaap:CommonStockMember2023-01-012023-03-310001280784htgc:CapitalInExcessOfParValueMember2023-01-012023-03-310001280784us-gaap:CommonStockMember2023-03-310001280784htgc:CapitalInExcessOfParValueMember2023-03-310001280784htgc:DistributableEarningsLossMember2023-03-3100012807842023-03-310001280784Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee2024-03-31xbrli:pure0001280784Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 7.85% Exit Fee2024-03-310001280784Debt Investments Biotechnology Tools (2.57%)2024-03-310001280784Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee2024-03-310001280784Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month SOFR + 10.50%, Floor rate 11.40%2024-03-310001280784Debt Investments Communications & Networking (1.56%)2024-03-310001280784Debt Investments Consumer & Business Services and Altumint, Inc. Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee2024-03-31iso4217:GBP0001280784Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 8.50%2024-03-310001280784Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86, Floor rate 9.75%, 3.00% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Plentific Ltd. Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%2024-03-310001280784Debt Investments Consumer & Business Services and Riviera Partners LLC. Senior Secured, Maturity Date April 2027, 3-month SOFR + 8.26%, Floor rate 9.26%2024-03-310001280784Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%2024-03-310001280784Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Total SeatGeek, Inc.2024-03-310001280784Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25%2024-03-310001280784Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50%2024-03-310001280784Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee2024-03-310001280784Debt Investments Consumer & Business Services, and Total Veem, Inc.2024-03-310001280784Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2026, 3-month SOFR + 9.40%, Floor rate 10.25%2024-03-310001280784Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2026, 1-month SOFR + 9.35%, Floor rate 10.25%2024-03-310001280784Debt Investments Consumer & Business Services and Total Worldremit Group Limited2024-03-310001280784Debt Investments Consumer & Business Services (27.71%)2024-03-310001280784Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 11.50%2024-03-310001280784Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), UnSecured, Maturity Date September 2026, Fixed + 11.95%2024-03-310001280784Debt Investments Diversified Financial Services and Total Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC)2024-03-310001280784Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%2024-03-310001280784Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime -(1.50%), Floor rate 4.75%, PIK Interest 5.50%2024-03-310001280784Debt Investments Diversified Financial Services (3.04%)2024-03-310001280784Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and bluebird bio, Inc. Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 4.95% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and COMPASS Pathways plc Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 4.00% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 10.31% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc.. Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.06% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Verona Pharma, Inc. Senior Secured, Maturity Date December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee2024-03-310001280784Debt Investments Drug Discovery & Development (61.36%)2024-03-310001280784Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee2024-03-310001280784Debt Investments Electronics & Computer Hardware and Shield AI, Inc. Senior Secured, Maturity Date February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee2024-03-310001280784Debt Investments Electronics & Computer Hardware (3.97%)2024-03-310001280784Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45%2024-03-310001280784Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2026, Prime - (1.50%), Floor rate 7.00%, PIK Interest 7.00%, 5.64% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%2024-03-310001280784Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Marathon Health, LLC Senior Secured, Maturity Date February 2029,Prime - (0.90%), Floor rate 7.10%, PIK Interest 4.00%, 3.00% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Recover Together, Inc. Senior Secured, Maturity Date July 2027 Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee2024-03-310001280784Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Feesrt:MinimumMember2024-03-310001280784Debt Investments Healthcare Services, Other (25.39%)2024-03-310001280784Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee2024-03-310001280784Debt Investments Information Services and Checkr Group, Inc. Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee2024-03-310001280784Debt Investments Information Services and Saama Technologies, LLC Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee2024-03-310001280784Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee2024-03-310001280784Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 8.42%, Floor rate 9.32%2024-03-310001280784Debt Investments Information Services (6.49%)2024-03-310001280784Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee2024-03-310001280784Debt Investments Manufacturing Technology (0.38%)2024-03-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee2024-03-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2024-03-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2024-03-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2024-03-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc. , Senior Secured, Maturity Date June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2024-03-310001280784Debt Investments Media/Content/Info and Total Fever Labs, Inc.2024-03-310001280784Debt Investments Media/Content/Info (0.63%)2024-03-310001280784Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Senior Secured, Maturity Date September 2027 Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee2024-03-310001280784Debt Investments Medical Devices & Equipment and Sight Sciences, Inc. Senior Secured, Maturity Date July 2028 Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee2024-03-310001280784Debt Investments Medical Devices & Equipment (2.89%) 2024-03-310001280784Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.86%, Floor rate 10.76%2024-03-310001280784Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.96%, Floor rate 7.86%2024-03-310001280784Debt Investments Software and Total 3GTMS, LLC2024-03-310001280784Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%2024-03-310001280784Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%2024-03-310001280784Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 7.25%, Floor rate 8.25%2024-03-310001280784Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 10.00%, Floor rate 11.00%2024-03-310001280784Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee2024-03-310001280784Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee2024-03-310001280784Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 6-month SOFR + 8.01%, Floor rate 9.01%2024-03-310001280784Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, PRIME + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee2024-03-310001280784Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.41%, Floor rate 11.81%2024-03-310001280784Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 8.99%, Floor rate 9.89%2024-03-310001280784Debt Investments Software and Constructor io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%2024-03-310001280784Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee2024-03-310001280784Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.77% Exit Fee2024-03-310001280784Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee12024-03-310001280784Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee22024-03-310001280784Debt Investments Software and Total Cutover, Inc.2024-03-310001280784Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38%2024-03-310001280784Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11%2024-03-310001280784Debt Investments Software and Total Cybermaxx Intermediate Holdings, Inc.2024-03-310001280784Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.35% Exit Fee2024-03-310001280784Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%2024-03-310001280784Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee2024-03-310001280784Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee2024-03-310001280784Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee2024-03-310001280784Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70%2024-03-310001280784Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 1-month SOFR + 7.64%, Floor rate 8.54%2024-03-310001280784Debt Investments Software and Harness, Inc., Senior Secured, Maturity Date March 2029, Prime - (2.25%), Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee2024-03-310001280784Debt Investments Software and iGrafx, LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.61%, Floor rate 9.51%2024-03-310001280784Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month SOFR + 9.26%, Floor rate 10.00%2024-03-310001280784Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50%2024-03-310001280784Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee2024-03-310001280784Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15%2024-03-310001280784Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%2024-03-310001280784Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%2024-03-310001280784Debt Investments Software and Marigold Group, Inc. (p.k.a. Campaign Monitor Limited), Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.05%, Floor rate 9.90%2024-03-310001280784Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 6-month SOFR + 9.21%, Floor rate 10.06%2024-03-310001280784Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75%2024-03-310001280784Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%2024-03-310001280784Debt Investments Software and Onna Technologies, Inc., Senior Secured, Maturity Date March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest, 1.75%, 4.45% Exit Fee2024-03-310001280784Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee2024-03-310001280784Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 6-month SOFR + 8.98%, Floor rate 9.88%2024-03-310001280784Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.48% Exit Fee2024-03-310001280784Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee2024-03-310001280784Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.25%, Floor rate 8.25%2024-03-310001280784Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 6-month SOFR + 7.25%, Floor rate 8.25%2024-03-310001280784Debt Investments Software , Total Streamline Healthcare Solutions2024-03-310001280784Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50%2024-03-310001280784Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee2024-03-310001280784Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month SOFR + 9.25%, Floor rate 10.00%2024-03-310001280784Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee2024-03-310001280784Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%2024-03-310001280784Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%2024-03-310001280784Debt Investments Software (42.47%)2024-03-310001280784Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee2024-03-310001280784Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.25% Exit Fee2024-03-310001280784Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00%2024-03-310001280784Debt Investments Sustainable and Renewable Technology (0.93%)2024-03-310001280784Debt Investments (179.38%)2024-03-310001280784Equity Investments Biotechnology Tools Alamar Biosciences, Inc and Equity, Acquisition Date 2/21/2024, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Biotechnology Tools Alamar Biosciences, Inc and Equity, Acquisition Date 2/21/2024, Series Preferred Series C2024-03-310001280784Equity Investments Biotechnology Tools (0.08%)2024-03-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B2024-01-012024-03-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B2024-03-310001280784Equity Investments Consumer & Business Products and Total Fabletics, Inc.2024-03-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units2024-01-012024-03-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units2024-03-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Products (0.12%)2024-03-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42024-03-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2024-03-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-12024-01-012024-03-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-12024-03-310001280784Equity Investments Consumer & Business Services and Total OfferUp, Inc.2024-03-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2024-03-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2024-03-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C2024-03-310001280784Equity Investments Consumer & Business Services and Total Tectura Corporation2024-03-310001280784Equity Investments Consumer & Business Services (0.52%)2024-03-310001280784Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units2024-01-012024-03-310001280784Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units2024-03-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2024-01-012024-03-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2024-03-310001280784Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22024-01-012024-03-310001280784Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22024-03-310001280784Equity Investments Diversified Financial Services (2.84%)2024-03-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2024-03-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2024-01-012024-03-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2024-03-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2024-03-310001280784Equity Investments Drug Delivery and Talphera, Inc, Equity, Acquisition Date 12/10/2018, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Delivery and Talphera, Inc, Equity, Acquisition Date 12/10/2018, Series Common Stock2024-03-310001280784Equity Investments Drug Delivery (0.00%)2024-03-310001280784Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 3/8/2024, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 3/8/2024, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc., Equity, Acquisition Date 4/6/2021, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc., Equity, Acquisition Date 4/6/2021, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B2024-03-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C2024-03-310001280784Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B2024-03-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C2024-03-310001280784Equity Investments Drug Discovery & Development, Total Valo Health LLC2024-03-310001280784Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C2024-03-310001280784Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc Equity, Acquisition Date 11/6/2023, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc Equity, Acquisition Date 11/6/2023, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock2024-01-012024-03-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock2024-03-310001280784Equity Investments Drug Discovery & Development (2.63%)2024-03-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2024-01-012024-03-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2024-03-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2024-01-012024-03-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2024-03-310001280784Equity Investments Electronics & Computer Hardware (0.04%)2024-03-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2024-01-012024-03-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2024-03-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2024-03-310001280784Equity Investments Healthcare Services, Other (0.03%)2024-03-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2024-01-012024-03-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2024-03-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2024-01-012024-03-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2024-03-310001280784Equity Investments Information Services (0.31%)2024-03-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2024-01-012024-03-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2024-03-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22024-01-012024-03-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22024-03-310001280784Equity Investments Medical Devices & Equipment, Total Coronado Aesthetics, LLC2024-03-310001280784Equity Investments Medical Devices & Equipment (0.02%)2024-03-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2024-03-310001280784Equity Investments Semiconductors (0.02%)2024-03-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2024-01-012024-03-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2024-03-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2024-01-012024-03-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2024-03-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32024-01-012024-03-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32024-03-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2024-03-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2024-01-012024-03-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2024-03-310001280784Equity Investments Software, Total Contentful Global, Inc.2024-03-310001280784Equity Investments Software and DNAnexus, Inc, Equity, Acquisition Date 3/21/2014, Series Preferred Series C2024-01-012024-03-310001280784Equity Investments Software and DNAnexus, Inc, Equity, Acquisition Date 3/21/2014, Series Preferred Series C2024-03-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2024-01-012024-03-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2024-03-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22024-01-012024-03-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22024-03-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32024-01-012024-03-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32024-03-310001280784Equity Investments Software, Total Druva Holdings, Inc.2024-03-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2024-01-012024-03-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2024-03-310001280784Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B22024-01-012024-03-310001280784Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B22024-03-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2024-01-012024-03-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2024-03-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2024-01-012024-03-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2024-03-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2024-01-012024-03-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2024-03-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2024-01-012024-03-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2024-03-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2024-01-012024-03-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2024-03-310001280784Equity Investments Software, Total SingleStore, Inc.2024-03-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2024-01-012024-03-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2024-03-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2024-01-012024-03-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2024-03-310001280784Equity Investments Software (1.18%)2024-03-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12024-01-012024-03-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12024-03-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 3/10/2019, Series Preferred Series E-12024-01-012024-03-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 3/10/2019, Series Preferred Series E-12024-03-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2024-01-012024-03-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2024-03-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2024-01-012024-03-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2024-03-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2024-01-012024-03-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2024-03-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2024-01-012024-03-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2024-03-310001280784Equity Investments Sustainable and Renewable Technology (0.17%)2024-03-310001280784Equity Investments (7.96%)2024-03-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series B2024-01-012024-03-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series B2024-03-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock2024-03-310001280784Warrant Investments and Biotechnology Tools (0.02%)2024-03-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock2024-03-310001280784Warrant Investments and Communications & Networking (0.01%)2024-03-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C2024-03-310001280784Warrant Investments and Consumer & Business Products (0.02%)2024-03-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-42024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-42024-03-310001280784Warrant Investments and Consumer & Business Services , Total Carwow LTD2024-03-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D2024-03-310001280784Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares2024-03-310001280784Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B2024-03-310001280784Warrant Investments and Consumer & Business Services and Total Skyword, Inc.2024-03-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A2024-03-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B2024-03-310001280784Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc.2024-03-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2024-03-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D2024-03-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E2024-01-012024-03-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E2024-03-310001280784Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited2024-03-310001280784Warrant Investments and Consumer & Business Services (0.27%)2024-03-310001280784Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock2024-03-310001280784Warrant Investments and Diversified Financial Services (0.03%)2024-03-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Series Common Stock2024-03-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Series Common Stock2024-03-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Series Common Stock2024-03-310001280784Warrant Investments and Drug Delivery (0.00%)2024-03-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock2024-03-310001280784 Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Series Class A Units2024-01-012024-03-310001280784 Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Series Class A Units2024-03-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and blubird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and blubird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B2024-03-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares2024-03-310001280784Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E2024-03-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units2024-03-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock2024-03-310001280784Warrant Investments and Drug Discovery & Development (0.59%)2024-03-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock2024-03-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock2024-03-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock2024-03-310001280784Warrant Investments and Electronics & Computer Hardware (0.02%)2024-03-310001280784Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC., Warrant, Acquisition Date 1/4/2024, Series Common Units2024-01-012024-03-310001280784Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC., Warrant, Acquisition Date 1/4/2024, Series Common Units2024-03-310001280784Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Series Common Stock2024-03-310001280784Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Series Common Stock2024-03-310001280784Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Series Common Units2024-01-012024-03-310001280784Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Series Common Units2024-03-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Common Stock2024-03-310001280784Warrant Investments and Healthcare Services, Other (0.03%)2024-03-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock2024-03-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Series Common Stock2024-03-310001280784Warrant Investments and Information Services and NetBase Quid, Inc. (p.k.a NetBase Solutions), Warrant, Acquisition Date 8/22/2017, Series Preferred Series 12024-01-012024-03-310001280784Warrant Investments and Information Services and NetBase Quid, Inc. (p.k.a NetBase Solutions), Warrant, Acquisition Date 8/22/2017, Series Preferred Series 12024-03-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock2024-03-310001280784Warrant Investments and Information Services (0.00%)2024-03-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2024-03-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock2024-03-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Series Common Stock2024-03-310001280784Warrant Investments and Manufacturing Technology (0.07%)2024-03-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-12024-01-012024-03-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-12024-03-310001280784Warrant Investments and Media/Content/Info (0.01%)2024-03-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Series Preferred Series B-12024-01-012024-03-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Series Preferred Series B-12024-03-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Series Common Stock2024-03-310001280784Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Series Common Stock2024-03-310001280784Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock2024-03-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock2024-03-310001280784Warrant Investments and Medical Devices & Equipment (0.03%)2024-03-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-22024-01-012024-03-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-22024-03-310001280784Warrant Investments and Semiconductors (0.04%)2024-03-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G2024-01-012024-03-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G2024-03-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock2024-03-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock2024-03-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock2024-03-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2024-03-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock2024-03-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B2024-01-012024-03-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B2024-03-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock2024-03-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock2024-03-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock2024-03-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock2024-03-310001280784Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock2024-03-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock2024-03-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Series Common Stock2024-03-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock2024-03-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B2024-01-012024-03-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B2024-03-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock2024-03-310001280784Warrant Investments and Software and Harness, Inc., Warrant, Acquisition Date 3/12/2024, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Harness, Inc., Warrant, Acquisition Date 3/12/2024, Series Common Stock2024-03-310001280784Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C2024-01-012024-03-310001280784Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C2024-03-310001280784Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock2024-03-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series D2024-01-012024-03-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series D2024-03-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2024-03-310001280784Warrant Investments and Software and Onna Technologies, Inc., Warrant 7/5/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Onna Technologies, Inc., Warrant 7/5/2023, Series Common Stock2024-03-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Series Common Stock2024-03-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock2024-03-310001280784Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock2024-03-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D2024-01-012024-03-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D2024-03-310001280784Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Series Ordinary Shares2024-01-012024-03-310001280784Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Series Ordinary Shares2024-03-310001280784Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023, Series Common Stock2024-03-310001280784Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares2024-01-012024-03-310001280784Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares2024-03-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock2024-03-310001280784Warrant Investments and Software (0.54%)2024-03-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Series Common Stock2024-03-310001280784Warrant Investments and Surgical Devices (0.03%)2024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock2024-01-012024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock2024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common stock2024-01-012024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common stock2024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Series Common stock2024-01-012024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Series Common stock2024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Series Preferred Series C2024-01-012024-03-310001280784Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Series Preferred Series C2024-03-310001280784Warrant Investments and Sustainable and Renewable Technology (0.03%)2024-03-310001280784Warrant Investments (1.73%)2024-03-310001280784Investments in Securities (189.08%)2024-03-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202024-01-012024-03-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202024-03-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222024-01-012024-03-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222024-03-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development (0.29%)2024-03-310001280784Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222024-01-012024-03-310001280784Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222024-03-310001280784Investment Funds & Vehicles Investments and Software (0.02%)2024-03-310001280784Investment Funds & Vehicles Investments (0.31%)2024-03-310001280784Investments (189.38%)2024-03-310001280784Foreign Currency Exchange Contracts Counterparty Goldman Sachs Bank USA Settlement Date 6/3/20242024-01-012024-03-310001280784Foreign Currency Exchange Contracts Counterparty Goldman Sachs Bank USA Settlement Date 6/3/20242024-03-310001280784Total Foreign Currency Forward ((0.03%))2024-03-310001280784htgc:OneMonthSOFRMember2024-03-310001280784htgc:ThreeMonthSOFRMember2024-03-310001280784htgc:SixMonthSOFRMember2024-03-310001280784us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Member2024-03-31htgc:Firm0001280784us-gaap:FairValueInputsLevel1Memberus-gaap:CommonStockMember2024-03-310001280784htgc:PromissoryNotesMemberhtgc:BlackCrowAIIncMember2024-03-310001280784htgc:PhathomPharmaceuticalsIncMemberhtgc:RoyaltyContractMember2024-03-310001280784Debt Investment Biotechnology Tools and Alamar Biosciences, Inc., Senior Secured, June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee2023-12-310001280784Debt Investment Biotechnology Tools and PathAI, Inc., Senior Secured, January 2027, Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee2023-12-310001280784Debt Investment Biotechnology Tools (2.66%)2023-12-310001280784Debt Investment Communications & Networking and Aryaka Networks, Inc., Senior Secured, July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee2023-12-310001280784Debt Investment Communications & Networking and Cytracom Holdings LLC, Senior Secured, February 2025, 3-month SOFR + 9.72%, Floor rate 10.62%2023-12-310001280784Debt Investment Communications & Networking and (1.62%)2023-12-310001280784Debt Investment Consumer & Business Services and Altumint, Inc., Senior Secured, December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and AppDirect, Inc., Senior Secured, April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Carwow LTD, Senior Secured, December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 8.50%2023-12-310001280784Debt Investment Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Provi, Senior Secured, December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Rhino Labs, Inc., Senior Secured, June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%2023-12-310001280784Debt Investment Consumer & Business Services and Riviera Partners LLC, Senior Secured, April 2027, 3-month SOFR + 8.26%, Floor rate 9.26%2023-12-310001280784Debt Investment Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%2023-12-310001280784Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Total SeatGeek, Inc2023-12-310001280784Debt Investment Consumer & Business Services and Skyword, Inc., Senior Secured, November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Tectura Corporation, Senior Secured, July 2024, FIXED 8.25%2023-12-310001280784Debt Investment Consumer & Business Services and Thumbtack, Inc., Senior Secured, April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Udacity, Inc., Senior Secured, September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Total Veem, Inc.,2023-12-310001280784Debt Investment Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee2023-12-310001280784Debt Investment Consumer & Business Services and Total Worldremit Group Limited2023-12-310001280784Debt Investment Consumer & Business Services (28.24%)2023-12-310001280784Debt Investment Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, September 2026, FIXED 11.50%2023-12-310001280784Debt Investment Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, September 2026, FIXED 11.95%2023-12-310001280784Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC2023-12-310001280784Debt Investment Diversified Financial Services and Hercules Adviser LLC, Unsecured, June 2025, FIXED 5.00%2023-12-310001280784Debt Investment Diversified Financial Services and Next Insurance, Inc., Senior Secured, February 2028, Prime - (1.50%), Floor rate 4.75%, PIK Interest 5.50%2023-12-310001280784Debt Investment Diversified Financial Services (3.17%)2023-12-310001280784Debt Investment Drug Discovery & Development and Akero Therapeutics, Inc., Senior Secured, January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Alladapt Immunotherapeutics Inc., Senior Secured, September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and ATAI Life Sciences N.V., Senior Secured, August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Axsome Therapeutics, Inc., Senior Secured, January 2028, Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and BiomX, INC, Senior Secured, September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Braeburn, Inc., Senior Secured, October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and BridgeBio Pharma, Inc., Senior Secured, November 2026, FIXED 9.00%, 2.00% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Cellarity, Inc., Senior Secured, June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Corium, Inc., Senior Secured, September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Curevo, Inc., Senior Secured, June 2027, Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Eloxx Pharmaceuticals, Inc., Senior Secured, April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and enGene, Inc., Senior Secured, July 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and G1 Therapeutics, Inc., Senior Secured, November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Geron Corporation, Senior Secured, April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Gritstone Bio, Inc., Senior Secured, July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Hibercell, Inc., Senior Secured, May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and HilleVax, Inc., Senior Secured, May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Locus Biosciences, Inc., Senior Secured, July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Redshift Bioanalytics, Inc., Senior Secured, January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Replimune Group, Inc., Senior Secured, October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Senior Secured, February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and TG Therapeutics, Inc., Senior Secured, January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and uniQure B.V., Senior Secured, January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Valo Health, LLC, Senior Secured, May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Verona Pharma, Inc., Senior Secured, December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee2023-12-310001280784Debt Investment Drug Discovery & Development (66.60%)2023-12-310001280784Debt Investment Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee2023-12-310001280784Debt Investment Electronics & Computer Hardware (1.05%)2023-12-310001280784Debt Investment Healthcare Services, Other and Better Therapeutics, Inc., Senior Secured, August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee2023-12-310001280784Debt Investment Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, November 2026, 1-month SOFR + 5.11% , Floor rate 6.00%, PIK Interest 4.45%2023-12-310001280784Debt Investment Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee2023-12-310001280784Debt Investment Healthcare Services, Other and Equality Health, LLC, Senior Secured, February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%2023-12-310001280784Debt Investment Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee2023-12-310001280784Debt Investment Healthcare Services, Other and Modern Life, Inc., Senior Secured, February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee2023-12-310001280784Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee2023-12-310001280784Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee2023-12-310001280784Debt Investment Healthcare Services, Other and Vida Health, Inc., Senior Secured, March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee2023-12-310001280784Debt Investment Healthcare Services, Other (16.56%)2023-12-310001280784Debt Investment Information Services and Capella Space Corp., Senior Secured, November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee2023-12-310001280784Debt Investment Information Services and Checkr Group, Inc., Senior Secured, August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee2023-12-310001280784Debt Investment Information Services and Saama Technologies, LLC, Senior Secured, July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee2023-12-310001280784Debt Investment Information Services and Signal Media Limited, Senior Secured, June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee2023-12-310001280784Debt Investment Information Services and Yipit, LLC, Senior Secured, September 2026, 1-month SOFR + 8.45%, Floor rate 9.35%2023-12-310001280784Debt Investment Information Services (6.65%)2023-12-310001280784Debt Investment Manufacturing Technology and Bright Machines, Inc., Senior Secured, May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee2023-12-310001280784Debt Investment Manufacturing Technology (0.44%)2023-12-310001280784Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee2023-12-310001280784Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investment Media/Content/Info and Total Fever Labs, Inc.2023-12-310001280784Debt Investment Media/Content/Info (0.69%)2023-12-310001280784Debt Investment Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee2023-12-310001280784Debt Investment Medical Devices & Equipment (1.20%)2023-12-310001280784Debt Investment Software and 3GTMS, LLC, Senior Secured, February 2025, 3-month SOFR + 9.70%, Floor rate 10.60%2023-12-310001280784Debt Investment Software and 3GTMS, LLC, Senior Secured, February 2025, 3-month SOFR + 6.88%, Floor rate 7.78%2023-12-310001280784Debt Investment Software and Total 3GTMS, LLC2023-12-310001280784Debt Investment Software and Agilence, Inc., Senior Secured, October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%2023-12-310001280784Debt Investment Software and Alchemer LLC, Senior Secured, May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%2023-12-310001280784Debt Investment Software and Allvue Systems, LLC, Senior Secured, September 2029, 6-month SOFR + 7.25%, Floor rate 8.25%2023-12-310001280784Debt Investment Software and Annex Cloud, Senior Secured, February 2027, 1-month BSBY + 9.41%, Floor rate 10.41%2023-12-310001280784Debt Investment Software and Automation Anywhere, Inc., Senior Secured, September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee2023-12-310001280784Debt Investment Software and Babel Street, Senior Secured, December 2027, 3-month SOFR + 7.89%, Floor rate 8.89%2023-12-310001280784Debt Investment Software and Brain Corporation, Senior Secured, April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee2023-12-310001280784Debt Investment Software and Campaign Monitor Limited, Senior Secured, November 2025, 3-month SOFR + 9.05%, Floor rate 9.90%2023-12-310001280784Debt Investment Software and Catchpoint Systems, Inc., Senior Secured, November 2025, 3-month SOFR + 9.41%, Floor rate 11.81%2023-12-310001280784Debt Investment Software and Ceros, Inc., Senior Secured, September 2026, 6-month SOFR + 8.99%, Floor rate 9.89%2023-12-310001280784Debt Investment Software and Constructor.io Corporation, Senior Secured, July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%2023-12-310001280784Debt Investment Software and Convoy, Inc., Senior Secured, March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee2023-12-310001280784Debt Investment Software and Copper CRM, Inc, Senior Secured, March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee2023-12-310001280784Debt Investment Software and Cutover, Inc., Senior Secured, October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee2023-12-310001280784Debt Investment Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, August 2026, 6-month SOFR + 8.63%, Floor rate 9.38%2023-12-310001280784Debt Investment Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, August 2026, 6-month SOFR + 12.36%, Floor rate 13.11%2023-12-310001280784Debt Investment Software and Total Cybermaxx Intermediate Holdings, Inc., 2023-12-310001280784Debt Investment Software and Dashlane, Inc., Senior Secured, December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee2023-12-310001280784Debt Investment Software and Dispatch Technologies, Inc., Senior Secured, April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%2023-12-310001280784Debt Investment Software and DroneDeploy, Inc., Senior Secured, July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee2023-12-310001280784Debt Investment Software and Eigen Technologies Ltd., Senior Secured, April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee2023-12-310001280784Debt Investment Software and Elation Health, Inc., Senior Secured, March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee2023-12-310001280784Debt Investment Software and Enmark Systems, Inc., Senior Secured, September 2026, 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13%2023-12-310001280784Debt Investment Software and Flight Schedule Pro, LLC, Senior Secured, October 2027, 1-month SOFR + 7.80%, Floor rate 8.70%2023-12-310001280784Debt Investment Software and Fortified Health Security, Senior Secured, December 2027, 1-month SOFR + 7.64%, Floor rate 8.54%2023-12-310001280784Debt Investment Software and iGrafx, LLC, Senior Secured, May 2027, 1-month SOFR + 8.66%, Floor rate 9.56%2023-12-310001280784Debt Investment Software and Ikon Science Limited, Senior Secured, October 2024, 3-month SOFR + 9.26%, Floor rate 10.00%2023-12-310001280784Debt Investment Software and Khoros (p.k.a Lithium Technologies), Senior Secured, January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50%2023-12-310001280784Debt Investment Software and Leapwork ApS, Senior Secured, February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee2023-12-310001280784Debt Investment Software and LinenMaster, LLC, Senior Secured, August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15%2023-12-310001280784Debt Investment Software and Loftware, Inc., Senior Secured, March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%2023-12-310001280784Debt Investment Software and LogicSource, Senior Secured, July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%2023-12-310001280784Debt Investment Software and Mobile Solutions Services, Senior Secured, December 2025, 6-month SOFR + 9.31%, Floor rate 10.06%2023-12-310001280784Debt Investment Software and New Relic, Inc., Senior Secured, November 2030, 3-month SOFR + 6.75%, Floor rate 7.75%2023-12-310001280784Debt Investment Software and Omeda Holdings, LLC, Senior Secured, July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%2023-12-310001280784Debt Investment Software and Onna Technologies, Inc., Senior Secured, March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest 1.75%, 4.45% Exit Fee2023-12-310001280784Debt Investment Software and Salary.com, LLC, Senior Secured, September 2027, 3-month SOFR + 8.00%, Floor rate 9.00%2023-12-310001280784Debt Investment Software and ShadowDragon, LLC, Senior Secured, December 2026, 1-month SOFR + 9.01%, Floor rate 9.91%2023-12-310001280784Debt Investment Software and Simon Data, Inc., Senior Secured, March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee2023-12-310001280784Debt Investment Software and Sisense Ltd., Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee2023-12-310001280784Debt Investment Software and Streamline Healthcare Solutions, Senior Secured, March 2028, 3-month SOFR + 7.25%, Floor rate 8.25%2023-12-310001280784Debt Investment Software and Sumo Logic, Inc., Senior Secured, May 2030, 3-month SOFR + 6.50%, Floor rate 7.50%2023-12-310001280784Debt Investment Software and Suzy, Inc., Senior Secured, August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee2023-12-310001280784Debt Investment Software and ThreatConnect, Inc., Senior Secured, May 2026, 6-month SOFR + 9.25%, Floor rate 10.00%2023-12-310001280784Debt Investment Software and Tipalti Solutions Ltd., Senior Secured, April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee2023-12-310001280784Debt Investment Software and Zappi, Inc., Senior Secured, December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%2023-12-310001280784Debt Investment Software and Zimperium, Inc., Senior Secured, May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%2023-12-310001280784Debt Investment Software (40.39%)2023-12-310001280784Debt Investment Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee2023-12-310001280784Debt Investment Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, June 2027, FIXED 10.00%2023-12-310001280784Debt Investment Sustainable and Renewable Technology (0.31%)2023-12-310001280784Total Debt Investments (169.59%)2023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Preferred Series B2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Preferred Series B2023-12-310001280784Equity Investments Consumer & Business Products and Total Fabletics, Inc.2023-12-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Equity, Acquisition Date 4/30/2021, Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Equity, Acquisition Date 4/30/2021, Common Stock2023-12-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Equity, Acquisition Date 4/30/2010, Class A Units2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Equity, Acquisition Date 4/30/2010, Class A Units2023-12-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Products (0.13%)2023-12-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42023-12-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2023-12-310001280784Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date10/25/2016, Series Preferred Series A-12023-01-012023-12-310001280784Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date10/25/2016, Series Preferred Series A-12023-12-310001280784Equity Investments Consumer & Business Services and Total OfferUp, Inc.2023-12-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C2023-12-310001280784Equity Investments Consumer & Business Services and Total Tectura Corporation2023-12-310001280784Equity Investments Consumer & Business Services (0.70%)2023-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units2023-01-012023-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units2023-12-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2023-01-012023-12-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2023-12-310001280784Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22023-01-012023-12-310001280784Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22023-12-310001280784Equity Investments Diversified Financial Services (3.17%)2023-12-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2023-12-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2023-01-012023-12-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2023-12-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2023-12-310001280784Equity Investments Drug Delivery and Talphera, Inc. (p.k.a. AcelRx Pharmaceuticals, Inc.), Equity, Acquisition Date 12/10/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Delivery and Talphera, Inc. (p.k.a. AcelRx Pharmaceuticals, Inc.), Equity, Acquisition Date 12/10/2018, Series Common Stock2023-12-310001280784Equity Investments Drug Delivery (0.00%)2023-12-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc.., Equity, Acquisition Date 5/9/2022, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc.., Equity, Acquisition Date 5/9/2022, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport)., Equity, Acquisition Date 4/06/2021, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport)., Equity, Acquisition Date 4/06/2021, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B2023-12-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, Acquisition Date 5/3/2022, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, Acquisition Date 5/3/2022, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C2023-12-310001280784Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B2023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C2023-12-310001280784Equity Investments Drug Discovery & Development and Total Valo Health, LLC2023-12-310001280784Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C2023-12-310001280784Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development (2.47%)2023-12-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2023-01-012023-12-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2023-12-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2023-12-310001280784Equity Investments Electronics & Computer Hardware (0.05%)2023-12-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2023-01-012023-12-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2023-12-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2023-12-310001280784Equity Investments Healthcare Services, Other (0.05%)2023-12-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2023-01-012023-12-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2023-12-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2023-12-310001280784Equity Investments Information Services (0.35%)2023-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2023-01-012023-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2023-12-310001280784Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22023-01-012023-12-310001280784Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22023-12-310001280784Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC2023-12-310001280784Equity Investments Medical Devices & Equipment (0.01%)2023-12-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2023-12-310001280784Equity Investments Semiconductors (0.02%)2023-12-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2023-12-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2023-01-012023-12-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2023-12-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32023-01-012023-12-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2023-01-012023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2023-12-310001280784Equity Investments Software and Total Contentful Global, Inc.2023-12-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22023-01-012023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32023-01-012023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32023-12-310001280784Equity Investments Software and Total Druva Holdings, Inc.2023-12-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2023-12-310001280784Equity Investments Software and Leapwork ApS, Equity, Acquisition Date 8/25/2023, Preferred Series B22023-01-012023-12-310001280784Equity Investments Software and Leapwork ApS, Equity, Acquisition Date 8/25/2023, Preferred Series B22023-12-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2023-12-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2023-12-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2023-01-012023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2023-12-310001280784Equity Investments Software and Total SingleStore, Inc.2023-12-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2023-12-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2023-12-310001280784Equity Investments Software (1.27%)2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12023-12-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-12023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-12023-12-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2023-12-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock2023-12-310001280784Equity Investments Sustainable and Renewable Technology (0.22%)2023-12-310001280784Equity Investments (8.44%)2023-12-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series B2023-12-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock2023-12-310001280784Warrant Investments and Biotechnology Tools (0.02%)2023-12-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock2023-12-310001280784Warrant Investments and Communications & Networking (0.01%)2023-12-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C2023-12-310001280784Warrant Investments and Consumer & Business Products (0.02%)2023-12-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D2023-12-310001280784Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary shares2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary shares2023-12-310001280784Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B2023-12-310001280784Warrant Investments and Consumer & Business Services and Total Skyword, Inc.2023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A2023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B2023-12-310001280784Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc.2023-12-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D2023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E2023-12-310001280784Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited2023-12-310001280784Warrant Investments and Consumer & Business Services (0.23%)2023-12-310001280784Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock2023-12-310001280784Warrant Diversified Financial Services (0.03%)2023-12-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Series Common Stock2023-12-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Series Common Stock2023-12-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Series Common Stock2023-12-310001280784Warrant Investments and Drug Delivery (0.00%)2023-12-310001280784Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc.., Warrant, Acquisition Date 2/24/2014 Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc.., Warrant, Acquisition Date 2/24/2014 Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and AmplifyBio, Warrant, Acquisition Date 12/27/2022, Series Class A Units2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and AmplifyBio, Warrant, Acquisition Date 12/27/2022, Series Class A Units2023-12-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B2023-12-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares2023-12-310001280784Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2019, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E2023-12-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/218/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/218/2019, Series Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development (0.46%)2023-12-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock2023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock2023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock2023-12-310001280784Warrant Investments and Electronics & Computer Hardware (0.02%)2023-12-310001280784Warrant Investments and Healthcare Services, Other and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock2023-12-310001280784Warrant Investments and Healthcare Services, Other and Recover Together, Inc., , Warrant, Acquisition Date 7/3/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Recover Together, Inc., , Warrant, Acquisition Date 7/3/2023, Series Common Stock2023-12-310001280784Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Warrant, Acquisition Date 9/28/2023, Series Common Units2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Warrant, Acquisition Date 9/28/2023, Series Common Units2023-12-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Warrant, Acquisition Date 3/28/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Warrant, Acquisition Date 3/28/2022, Series Common Stock2023-12-310001280784Warrant Investments and Healthcare Services, Other (0.03%)2023-12-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock2023-12-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Series Common Stock2023-12-310001280784Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 12023-01-012023-12-310001280784Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 12023-12-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock2023-12-310001280784Warrant Investments and Information Services (0.03%)2023-12-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock2023-12-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock2023-12-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Series Common Stock2023-12-310001280784Warrant Investments and Manufacturing Technology (0.17%)2023-12-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-12023-01-012023-12-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-12023-12-310001280784Warrant Investments and Media/Content/Info (0.01%)2023-12-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Series Preferred Series B-12023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Series Preferred Series B-12023-12-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical Inc, Warrant, Acquisition Date 9/27/2013, Series Common stock2023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical Inc, Warrant, Acquisition Date 9/27/2013, Series Common stock2023-12-310001280784Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock2023-12-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock2023-12-310001280784Warrant Investments and Medical Devices & Equipment (0.01%)2023-12-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-22023-01-012023-12-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-22023-12-310001280784Warrant Investments and Semiconductors (0.04%)2023-12-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G2023-01-012023-12-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G2023-12-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock2023-12-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock2023-12-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock2023-12-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2023-12-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock2023-12-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B2023-12-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock2023-12-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock2023-12-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock2023-12-310001280784Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Series Common Stock2023-12-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock2023-12-310001280784Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Series Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Series Preferred Series C2023-12-310001280784Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock2023-12-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock2023-12-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Series Common Stock2023-12-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock2023-12-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B2023-12-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock2023-12-310001280784Warrant Investments and Software and Kore, ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Software and Kore, ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C2023-12-310001280784Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock2023-12-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series D2023-12-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock2023-12-310001280784Warrant Investments and Software and Onna TechnologiesInc, Warrant, Acquisition Date 7/5/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Onna TechnologiesInc, Warrant, Acquisition Date 7/5/2023, Series Common Stock2023-12-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Series Common Stock2023-12-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock2023-12-310001280784Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock2023-12-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D2023-12-310001280784Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares2023-01-012023-12-310001280784Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares2023-12-310001280784Warrant Investments and Software and Suzy Inc, Warrant, Acquisition Date 8/24/2023, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Suzy Inc, Warrant, Acquisition Date 8/24/2023, Series Common Stock2023-12-310001280784Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Series Preferred Series AA2023-01-012023-12-310001280784Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Series Preferred Series AA2023-12-310001280784Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares2023-01-012023-12-310001280784Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares2023-12-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock2023-12-310001280784Warrant Investments and Software (0.75%)2023-12-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Series Common Stock2023-12-310001280784Warrant Investments and Surgical Devices (0.04%)2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Series Preferred Series A2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Series Preferred Series A2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Preferred Series B2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Total Halio, Inc., 2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Warrant, Polyera Corporation Acquisition Date 3/24/2015, Series Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Warrant, Polyera Corporation Acquisition Date 3/24/2015, Series Preferred Series C2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology (0.00%)2023-12-310001280784Total Warrant Investments (1.88%)2023-12-310001280784Investments in Securities (179.92%)2023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202023-01-012023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222023-01-012023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development (0.23%)2023-12-310001280784nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222023-01-012023-12-310001280784nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222023-12-310001280784Investment Funds & Vehicles Investments and Software (0.02%)2023-12-310001280784Investment Funds & Vehicles Investments (0.26%)2023-12-310001280784Investments (180.18%)2023-12-310001280784Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W2732023-12-310001280784Investment Fund In Cash & Cash Equivalents (3.11%)2023-12-310001280784Investment Fund After Cash & Cash Equivalents (183.28%)2023-12-310001280784Foreign Currency Exchange Contracts, Great British Pound (GBP) Counterparty Goldman Sachs Bank USA Settlement Date 6/3/20242023-01-012023-12-310001280784Foreign Currency Exchange Contracts, Great British Pound (GBP) Counterparty Goldman Sachs Bank USA Settlement Date 6/3/20242023-12-310001280784Total Foreign Currency Forward ((0.04%))2023-12-310001280784htgc:OneMonthSOFRMember2023-12-310001280784htgc:ThreeMonthSOFRMember2023-12-310001280784htgc:SixMonthSOFRMember2023-12-310001280784us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Member2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:CommonStockMember2023-12-310001280784htgc:PromissoryNotesMemberhtgc:BlackCrowAIIncMember2023-12-310001280784htgc:PhathomPharmaceuticalsIncMemberhtgc:RoyaltyContractMember2023-12-3100012807842023-01-012023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2024-03-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:WarrantMember2024-03-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:WarrantMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMember2024-03-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsForeignMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:InvestmentsExcludingDerivativeInstrumentsIncludingCashAndCashEquivalentsAndOtherAssetsMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:DerivativeInstrumentMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:IncludingCashAndCashEquivalentsAndDerivativeInstrumentsMember2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:WarrantMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:WarrantMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsForeignMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:InvestmentsExcludingDerivativeInstrumentsIncludingCashAndCashEquivalentsAndOtherAssetsMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:DerivativeInstrumentMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:IncludingCashAndCashEquivalentsAndDerivativeInstrumentsMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2024-01-012024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel3Member2023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel3Member2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel3Member2023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2023-01-012023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowReceivableMemberus-gaap:FairValueInputsLevel3Member2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowReceivableMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowReceivableMemberus-gaap:FairValueInputsLevel3Member2023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-03-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-01-012024-03-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-01-012023-03-310001280784htgc:PreferredStockInvestmentMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784htgc:PreferredStockInvestmentMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784htgc:CommonStockInvestmentMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784htgc:CommonStockInvestmentMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784htgc:WarrantInvestmentMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310001280784htgc:WarrantInvestmentMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMembersrt:WeightedAverageMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:TechnologyMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:TechnologyMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:TechnologyMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:IncomeApproachValuationTechniqueMemberhtgc:TechnologyMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784us-gaap:IncomeApproachValuationTechniqueMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:IncomeApproachValuationTechniqueMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:IncomeApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784htgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:ValuationTechniqueLiquidationMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:ValuationTechniqueLiquidationMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Memberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:MedicalDevicesMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:MedicalDevicesMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MedicalDevicesMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MedicalDevicesMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:MedicalDevicesMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:MedicalDevicesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:MedicalDevicesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMembersrt:MaximumMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CostApproachValuationTechniqueMemberhtgc:DebtInvestmentsMember2024-03-310001280784htgc:DebtInvestmentsImminentPayoffsMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784htgc:DebtMaturingWithinOneYearMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2024-03-310001280784htgc:ValuationTechniqueLiquidationMemberhtgc:OtherInvestmentReceivableMemberhtgc:OtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:ValuationTechniqueLiquidationMemberhtgc:OtherInvestmentReceivableMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberhtgc:OtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:ValuationTechniqueLiquidationMembersrt:MaximumMemberhtgc:OtherInvestmentReceivableMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:OtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:ValuationTechniqueLiquidationMembersrt:WeightedAverageMemberhtgc:OtherInvestmentReceivableMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:OtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:DebtInvestmentsAndOtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:PharmaceuticalsMemberhtgc:ValuationTechniqueLiquidationMembersrt:WeightedAverageMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:TechnologyMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:TechnologyMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:TechnologyMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:IncomeApproachValuationTechniqueMemberhtgc:TechnologyMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:IncomeApproachValuationTechniqueMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:IncomeApproachValuationTechniqueMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:IncomeApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784htgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:ValuationTechniqueLiquidationMembersrt:MaximumMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:ValuationTechniqueLiquidationMembersrt:WeightedAverageMemberhtgc:TechnologyMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Memberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:MeasurementInputHypotheticalMarketYieldMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:MinimumMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberhtgc:LowerMiddleMarketMembersrt:MaximumMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CostApproachValuationTechniqueMemberhtgc:DebtInvestmentsMember2023-12-310001280784htgc:DebtInvestmentsImminentPayoffsMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784htgc:DebtMaturingWithinOneYearMemberus-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784htgc:ValuationTechniqueLiquidationMemberhtgc:OtherInvestmentReceivableMemberhtgc:OtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:ValuationTechniqueLiquidationMembersrt:WeightedAverageMemberhtgc:OtherInvestmentReceivableMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:OtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:DebtInvestmentsAndOtherInvestmentReceivablesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputTangibleBookValueMultipleMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputTangibleBookValueMultipleMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputTangibleBookValueMultipleMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2024-03-310001280784us-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2024-03-310001280784us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2024-03-310001280784srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2024-03-310001280784us-gaap:EquitySecuritiesMemberhtgc:ValuationTechniqueOtherMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MinimumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2024-03-310001280784us-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2024-03-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784htgc:ValuationTechniqueOtherMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2024-03-310001280784htgc:EquityAndWarrantInvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputTangibleBookValueMultipleMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputTangibleBookValueMultipleMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputTangibleBookValueMultipleMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2023-12-310001280784us-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2023-12-310001280784us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2023-12-310001280784srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2023-12-310001280784us-gaap:EquitySecuritiesMemberhtgc:ValuationTechniqueOtherMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2023-12-310001280784us-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MinimumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2023-12-310001280784us-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2023-12-310001280784us-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2023-12-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:ValuationTechniqueOtherMemberus-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2023-12-310001280784htgc:EquityAndWarrantInvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784htgc:TwoThousandThirtyThreeNotesMember2024-03-310001280784htgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784htgc:UnderwritingMemberhtgc:TwoThousandThirtyThreeNotesMember2024-03-310001280784htgc:UnderwritingMemberhtgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMember2024-03-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SBADebenturesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SBADebenturesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberhtgc:SBADebenturesMember2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JulyTwoThousandTwentyFourNotesMember2024-03-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveNotesMember2024-03-310001280784htgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784htgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixANotesMember2024-03-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixBNotesMember2024-03-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2024-03-310001280784htgc:SeptemberTwoThousandTwentySixNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784htgc:SeptemberTwoThousandTwentySixNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2024-03-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2024-03-310001280784htgc:TwoThousandThirtyThreeNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784us-gaap:FairValueInputsLevel2Memberhtgc:TwoThousandThirtyThreeNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MUFGBankFacilityMember2024-03-310001280784htgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784htgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SMBCFacilityMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SMBCFacilityMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SMBCFacilityMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2024-03-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SBADebenturesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SBADebenturesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberhtgc:SBADebenturesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JulyTwoThousandTwentyFourNotesMember2023-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveNotesMember2023-12-310001280784htgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixANotesMember2023-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixBNotesMember2023-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2023-12-310001280784htgc:SeptemberTwoThousandTwentySixNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:SeptemberTwoThousandTwentySixNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784htgc:TwoThousandThirtyThreeNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberhtgc:TwoThousandThirtyThreeNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MUFGBankFacilityMember2023-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SMBCFacilityMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SMBCFacilityMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SMBCFacilityMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:CoronadoAestheticsLLCMember2024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:CoronadoAestheticsLLCMember2024-01-012024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:GibraltarAcquisitionLLCMember2024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:GibraltarAcquisitionLLCMember2024-01-012024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:HerculesAdviserLLCMember2024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:HerculesAdviserLLCMember2024-01-012024-03-310001280784htgc:TecturaCorporationMemberus-gaap:InvestmentAffiliatedIssuerControlledMember2024-03-310001280784htgc:TecturaCorporationMemberus-gaap:InvestmentAffiliatedIssuerControlledMember2024-01-012024-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:CoronadoAestheticsLLCMember2023-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:CoronadoAestheticsLLCMember2023-01-012023-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:GibraltarAcquisitionLLCMember2023-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:GibraltarAcquisitionLLCMember2023-01-012023-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:HerculesAdviserLLCMember2023-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMemberhtgc:HerculesAdviserLLCMember2023-01-012023-03-310001280784htgc:TecturaCorporationMemberus-gaap:InvestmentAffiliatedIssuerControlledMember2023-03-310001280784htgc:TecturaCorporationMemberus-gaap:InvestmentAffiliatedIssuerControlledMember2023-01-012023-03-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2023-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:SeniorSecuredDebtMember2024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:SeniorSecuredDebtMember2024-01-012024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:SeniorSecuredDebtMember2023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:SeniorSecuredDebtMember2023-01-012023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:UnsecuredDebtMember2024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:UnsecuredDebtMember2024-01-012024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:UnsecuredDebtMember2023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:UnsecuredDebtMember2023-01-012023-12-310001280784us-gaap:PreferredStockMemberhtgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2024-03-310001280784us-gaap:PreferredStockMemberhtgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2024-01-012024-03-310001280784us-gaap:PreferredStockMemberhtgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2023-12-310001280784us-gaap:PreferredStockMemberhtgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2023-01-012023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:CommonStockMember2024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:CommonStockMember2024-01-012024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:CommonStockMember2023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberus-gaap:CommonStockMember2023-01-012023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:WarrantInvestmentMember2024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:WarrantInvestmentMember2024-01-012024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:WarrantInvestmentMember2023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:WarrantInvestmentMember2023-01-012023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:InvestmentFundsAndVehiclesMember2024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:InvestmentFundsAndVehiclesMember2024-01-012024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:InvestmentFundsAndVehiclesMember2023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMemberhtgc:InvestmentFundsAndVehiclesMember2023-01-012023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2024-01-012024-03-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2023-12-310001280784htgc:InvestmentTypeConcentrationRiskMemberhtgc:TotalInvestmentsBenchmarkMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:USus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:USus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:USus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:USus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:NLus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:NLus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:NLus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:NLus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:ILus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:ILus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:ILus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:ILus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DKus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DKus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DKus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DKus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DEus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DEus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DEus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMembercountry:DEus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberhtgc:OtherMemberus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberhtgc:OtherMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberhtgc:OtherMemberus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberhtgc:OtherMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberus-gaap:GeographicConcentrationRiskMember2024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberus-gaap:GeographicConcentrationRiskMember2023-12-310001280784htgc:TotalInvestmentsBenchmarkGeographicalMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001280784htgc:IndustrySectorConcentrationRiskMemberhtgc:DrugDiscoveryAndDevelopmentMember2024-03-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:DrugDiscoveryAndDevelopmentMember2024-01-012024-03-310001280784htgc:IndustrySectorConcentrationRiskMemberhtgc:DrugDiscoveryAndDevelopmentMember2023-12-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:DrugDiscoveryAndDevelopmentMember2023-01-012023-12-310001280784htgc:IndustrySectorConcentrationRiskMemberhtgc:SoftwareMember2024-03-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:SoftwareMember2024-01-012024-03-310001280784htgc:IndustrySectorConcentrationRiskMemberhtgc:SoftwareMember2023-12-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:SoftwareMember2023-01-012023-12-310001280784htgc:ConsumerAndBusinessServicesMemberhtgc:IndustrySectorConcentrationRiskMember2024-03-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:ConsumerAndBusinessServicesMember2024-01-012024-03-310001280784htgc:ConsumerAndBusinessServicesMemberhtgc:IndustrySectorConcentrationRiskMember2023-12-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:ConsumerAndBusinessServicesMember2023-01-012023-12-310001280784htgc:IndustrySectorConcentrationRiskMemberhtgc:HealthcareServicesOtherMember2024-03-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:HealthcareServicesOtherMember2024-01-012024-03-310001280784htgc:IndustrySectorConcentrationRiskMemberhtgc:HealthcareServicesOtherMember2023-12-310001280784htgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMemberhtgc:HealthcareServicesOtherMember2023-01-012023-12-310001280784htgc:InformationServicesMemberhtgc:IndustrySectorConcentrationRiskMember2024-03-310001280784htgc:InformationServicesMemberhtgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMember2024-01-012024-03-310001280784htgc:InformationServicesMemberhtgc:IndustrySectorConcentrationRiskMember2023-12-310001280784htgc:InformationServicesMemberhtgc:IndustrySubSectorInvestmentsBenchmarkMemberhtgc:IndustrySectorConcentrationRiskMember2023-01-012023-12-310001280784htgc:IndustrySectorConcentrationRiskMemberhtgc:DiversifiedFinancialServicesMember2024-03-310001280